Cargando…
Biologic therapies for Crohn’s disease: optimising the old and maximising the new
The era of biologic agents for the treatment of Crohn’s disease has brought about significant benefits for patients, and since the introduction of infliximab at the turn of the century, the entire field has moved on rapidly. Clinicians now have multiple agents at their disposal and a choice between...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668046/ https://www.ncbi.nlm.nih.gov/pubmed/31448080 http://dx.doi.org/10.12688/f1000research.18902.1 |